CE Exam Based Reference Study Guide

Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, Gropler RJ, Knuuti J, Schelbert HR, Travin MI. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol. 2016 Oct;23(5):1187-1226. doi: 10.1007/s12350-016-0522-3. Epub 2016 Jul 8. Erratum in: J Nucl Cardiol. 2023 Oct;30(5):2186. PMID: 27392702.

Di Carli, M.F. et al. (2022). Evaluation of Ischemic Heart Disease. In: Di Carli, M.F., Dondi, M., Giubbini, R., Paez, D. (eds) IAEA Atlas of Cardiac PET/CT. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-64499-7_2

Kim EJ, Kim BC, Kim SJ, Jung DS, Sin JS, Yoon YJ, Chin J, Lee KH, Na DL. Clinical staging of semantic dementia in an FDG-PET study using FTLD-CDR. Dement Geriatr Cogn Disord. 2012;34(5-6):300-6. doi: 10.1159/000345506. Epub 2012 Nov 30. PMID: 23208196.

Neumar RW, Otto CW, Link MS, Kronick SL, Shuster M, Callaway CW, Kudenchuk PJ, Ornato JP, McNally B, Silvers SM, Passman RS, White RD, Hess EP, Tang W, Davis D, Sinz E, Morrison LJ. Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010 Nov 2;122(18 Suppl 3):S729-67. doi: 10.1161/CIRCULATIONAHA.110.970988. Erratum in: Circulation. 2011 Feb 15;123(6):e236. Erratum in: Circulation. 2013 Dec 24;128(25):e480. PMID: 20956224.

Wackers FJT and Zaret BL: Nuclear Cardiology: The Basics

Koenders SS, van Dalen JA, Jager PL, Mouden M, Slump CH, van Dijk JD. Diagnostic value of regional myocardial flow reserve measurements using Rubidium-82 PET : Disclosures none. Int J Cardiovasc Imaging. 2022 Dec;38(12):2743-2751. doi: 10.1007/s10554-022-02644-6. Epub 2022 Aug 8. PMID: 36445671; PMCID: PMC9708774.

Burrell S, MacDonald A. Artifacts and pitfalls in myocardial perfusion imaging. J Nucl Med Technol. 2006 Dec;34(4):193-211; quiz 212-4. PMID: 17146108.

Braune S, Reinhardt M, Schnitzer R, Riedel A, Lücking CH. Cardiac uptake of [123I]MIBG separates Parkinson’s disease from multiple system atrophy. Neurology. 1999 Sep 22;53(5):1020-5. doi: 10.1212/wnl.53.5.1020. PMID: 10496261.

Agostini D, Verberne HJ, Hamon M, Jacobson AF, Manrique A. Cardiac 123I-MIBG scintigraphy in heart failure. Q J Nucl Med Mol Imaging. 2008 Dec;52(4):369-77. PMID: 19088691.

Bateman TM, Heller GV, Beanlands R, Calnon DA, Case J, deKemp R, DePuey EG, Di Carli M, Guler EC, Murthy VL, Rosenblatt J, Sher R, Slomka P, Ruddy TD. Practical Guide for Interpreting and Reporting Cardiac PET Measurements of Myocardial Blood Flow: An Information Statement from the American Society of Nuclear Cardiology, and the Society of Nuclear Medicine and Molecular Imaging. J Nucl Med. 2021 Nov;62(11):1599-1615. doi: 10.2967/jnumed.121.261989. Epub 2021 Mar 31. PMID: 33789935; PMCID: PMC8612323.

Mannarino T, Assante R, D’Antonio A, Zampella E, Cuocolo A, Acampa W. Radionuclide Tracers for Myocardial Perfusion Imaging and Blood Flow Quantification. Cardiol Clin. 2023 May;41(2):141-150. doi: 10.1016/j.ccl.2023.01.003. Epub 2023 Feb 23. PMID: 37003672.

Laukkanen JA, Mäkikallio TH, Rauramaa R, Kurl S. Asymptomatic ST-segment depression during exercise testing and the risk of sudden cardiac death in middle-aged men: a population-based follow-up study. Eur Heart J. 2009 Mar;30(5):558-65. doi: 10.1093/eurheartj/ehn584. Epub 2009 Jan 23. PMID: 19168533; PMCID: PMC2721711.

Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE 3rd, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russell RO, Smith SC Jr. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation. 2000 Sep 5;102(10):1193-209. doi: 10.1161/01.cir.102.10.1193. Erratum in: Circulation 2000 Oct 3;102(14):1739. PMID: 10973852.

ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures,

Thomas L, Joel K. PET systems (Chapter 10). In: Wernick Miles N, Aarsvold John N, editors. Emission tomography. San Diego: Elsevier Academic Press; 2004. p. 179–94

Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, Gropler RJ, Knuuti J, Schelbert HR, Travin MI. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol. 2016 Oct;23(5):1187-1226. doi: 10.1007/s12350-016-0522-3. Epub 2016 Jul 8. Erratum in: J Nucl Cardiol. 2023 Oct;30(5):2186. PMID: 27392702.

Regadenoson package insert, Astellas.

Roman CD, Habibian MR, Martin WH. Identification of an infected left ventricular assist device after cardiac transplant by indium-111 WBC scintigraphy. Clin Nucl Med. 2005 Jan;30(1):16-7. PubMed PMID: 15604960.

Retrospective Study Comparing WBC scan and 18F-FDG PET/CT in Patients with Suspected Prosthetic Vascular Graft Infection.  Puges, Mathilde et al. European Journal of Vascular and Endovascular Surgery, Volume 57, Issue 6, 876 – 884

Litzler PY, Manrique A, Etienne M, Salles A, Edet-Sanson A, Vera P, Bessou JP, Hitzel A. Leukocyte SPECT/CT for detecting infection of left-ventricular-assist devices: preliminary results. J Nucl Med. 2010 Jul;51(7):1044-8. doi: 10.2967/jnumed.109.070664. Epub 2010 Jun 16. PubMed PMID: 20554736.

Agarwal V, DePuey EG. Regadenoson and seizures: a real clinical concern. J Nucl Cardiol. 2014 Oct;21(5):869-70. doi: 10.1007/s12350-014-9970-9. Epub 2014 Aug 23. PMID: 25150095.

Chatal JF, Rouzet F, Haddad F, Bourdeau C, Mathieu C, Le Guludec D. Story of Rubidium-82 and Advantages for Myocardial Perfusion PET Imaging. Front Med (Lausanne). 2015 Sep 11;2:65. doi: 10.3389/fmed.2015.00065. PMID: 26442267; PMCID: PMC4566054.

Ghotbi AA, Kjaer A, Hasbak P. Review: comparison of PET rubidium-82 with conventional SPECT myocardial perfusion imaging. Clin Physiol Funct Imaging. 2014 May;34(3):163-70. doi: 10.1111/cpf.12083. Epub 2013 Sep 13. PMID: 24028171; PMCID: PMC4204510.

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020. PMID: 26462967; PMCID: PMC4739132

Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Müeller SP, Schwartz LH, Zucca E, Fisher RI, Trotman J, Hoekstra OS, Hicks RJ, O’Doherty MJ, Hustinx R, Biggi A, Cheson BD. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014 Sep 20;32(27):3048-58. doi: 10.1200/JCO.2013.53.5229. Erratum in: J Clin Oncol. 2016 Jul 20;34(21):2562. PMID: 25113771; PMCID: PMC5015423.

Allen BC, Francis IR. Adrenal Imaging and Intervention. Radiol Clin North Am. 2015 Sep;53(5):1021-35. doi: 10.1016/j.rcl.2015.05.004. PMID: 26321451.

Graham MM, Menda Y. Radiopeptide imaging and therapy in the United States. J Nucl Med. 2011 Dec;52 Suppl 2:56S-63S. doi: 10.2967/jnumed.110.085746. PMID: 22144556.

Greenspan BS, Dillehay G, Intenzo C, Lavely WC, O’Doherty M, Palestro CJ, Scheve W, Stabin MG, Sylvestros D, Tulchinsky M. SNM practice guideline for parathyroid scintigraphy 4.0. J Nucl Med Technol. 2012 Jun;40(2):111-8. doi: 10.2967/jnmt.112.105122. Epub 2012 Mar 27. PMID: 22454482.

Giovanella L, Avram AM, Iakovou I, Kwak J, Lawson SA, Lulaj E, Luster M, Piccardo A, Schmidt M, Tulchinsky M, Verburg FA, Wolin E. EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy. Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2514-2525. doi: 10.1007/s00259-019-04472-8. Epub 2019 Aug 7. PMID: 31392371.

ACR–SNM–SPR PRACTICE GUIDELINE FOR THE PERFORMANCE OF LIVER AND SPLEEN SCINTIGRAPHY, Revised 2010 (Res. 27)

Eldredge TA, Myers JC, Kiroff GK, Shenfine J. Detecting Bile Reflux-the Enigma of Bariatric Surgery. Obes Surg. 2018 Feb;28(2):559-566. doi: 10.1007/s11695-017-3026-6. PMID: 29230622.

Elsayes KM, Menias CO, Harvin HJ, Francis IR. Imaging manifestations of Meckel’s diverticulum. AJR Am J Roentgenol. 2007 Jul;189(1):81-8. doi: 10.2214/AJR.06.1257. PMID: 17579156.

Spottswood SE, Pfluger T, Bartold SP, Brandon D, Burchell N, Delbeke D, Fink-Bennett DM, Hodges PK, Jolles PR, Lassmann M, Maurer AH, Seabold JE, Stabin MG, Treves ST, Vlajkovic M; Society of Nuclear Medicine and Molecular Imaging; European Association of Nuclear Medicine. SNMMI and EANM practice guideline for Meckel diverticulum scintigraphy 2.0. J Nucl Med Technol. 2014 Sep;42(3):163-9. doi: 10.2967/jnmt.113.136242. Epub 2014 Jun 19. Erratum in: J Nucl Med Technol. 2016 Mar;44(1):51. PMID: 24948825.

Farrell MB. Gastric Emptying Scintigraphy. J Nucl Med Technol. 2019 Jun;47(2):111-119. doi: 10.2967/jnmt.117.227892. PMID: 31167827.

Woosley RD, Romero K, Heise CW, Gallo T, Tate J, Woosley RL. Summary of Torsades de Pointes (TdP) Reports Associated with Intravenous Drug Formulations Containing the Preservative Chlorobutanol. Drug Saf. 2019 Jul;42(7):907-913. doi: 10.1007/s40264-019-00804-7. PMID: 30888625.

Nuclear Medicine: The Requisites by Harvey A. Ziessman

Mittal BR, Kumar P, Arora P, Kher V, Singhal MK, Maini A, Das BK. Role of captopril renography in the diagnosis of renovascular hypertension. Am J Kidney Dis. 1996 Aug;28(2):209-13. doi: 10.1016/s0272-6386(96)90303-0. PMID: 8768915.

Rowe SP, Gorin MA, Gordetsky J, Ball MW, Pierorazio PM, Higuchi T, Epstein JI, Allaf ME, Javadi MS. Initial experience using 99mTc-MIBI SPECT/CT for the differentiation of oncocytoma from renal cell carcinoma. Clin Nucl Med. 2015 Apr;40(4):309-13. doi: 10.1097/RLU.0000000000000670. PMID: 25608174; PMCID: PMC4358706.

Boey CY, Yee SY, Amir Hassan SZ, Yahya R, Hashim H. Value of Baseline Post-Transplant MAG3 Renal Scintigraphy in the Evaluation of Graft Function. Transplant Proc. 2022 Mar;54(2):320-324. doi: 10.1016/j.transproceed.2021.12.016. Epub 2022 Jan 25. PMID: 35086676.

Alwis L, Hampson F, Pawaroo D, Balan K. Urinary reflux from ileal neobladder into a non-functioning kidney: detection during diuretic renography. Clin Nucl Med. 2009 Oct;34(10):725-6. doi: 10.1097/RLU.0b013e3181b53a0b. PMID: 19893415.

Boubaker A, Prior JO, Meuwly JY, Bischof-Delaloye A. Radionuclide investigations of the urinary tract in the era of multimodality imaging. J Nucl Med. 2006 Nov;47(11):1819-36. PMID: 17079816.

Hains DS, Bates CM, Ingraham S, Schwaderer AL. Management and etiology of the unilateral multicystic dysplastic kidney: a review. Pediatr Nephrol. 2009 Feb;24(2):233-41. doi: 10.1007/s00467-008-0828-8. Epub 2008 May 15. PMID: 18481111.

Shulkin BL, Mandell GA, Cooper JA, Leonard JC, Majd M, Parisi MT, Sfakianakis GN, Balon HR, Donohoe KJ. Procedure guideline for diuretic renography in children 3.0. J Nucl Med Technol. 2008 Sep;36(3):162-8. doi: 10.2967/jnmt.108.056622. PMID: 18765635.

Townley RA, Botha H, Graff-Radford J, Whitwell J, Boeve BF, Machulda MM, Fields JA, Drubach DA, Savica R, Petersen RC, Senjem ML, Knopman DS, Lowe VJ, Jack CR Jr, Josephs KA, Jones DT. Posterior cortical atrophy phenotypic heterogeneity revealed by decoding 18F-FDG-PET. Brain Commun. 2021 Aug 19;3(4):fcab182. doi: 10.1093/braincomms/fcab182. PMID: 34805993; PMCID: PMC8600283.

Brown RK, Bohnen NI, Wong KK, Minoshima S, Frey KA. Brain PET in suspected dementia: patterns of altered FDG metabolism. Radiographics. 2014 May-Jun;34(3):684-701. doi: 10.1148/rg.343135065. Erratum in: Radiographics. 2014 Jul-Aug;34(4):8A. PMID: 24819789.

Brown RK, Bohnen NI, Wong KK, Minoshima S, Frey KA. Brain PET in suspected dementia: patterns of altered FDG metabolism. Radiographics. 2014 May-Jun;34(3):684-701. doi: 10.1148/rg.343135065. Erratum in: Radiographics. 2014 Jul-Aug;34(4):8A. PMID: 24819789.

>Mercer MK, Revels JW, Blacklock LC, Banks KP, Johnson LS, Lewis DH, Kuo PH, Wilson S, Elojeimy S. Practical Overview of 123I-Ioflupane Imaging in Parkinsonian Syndromes. Radiographics. 2024 Feb;44(2):e230133. doi: 10.1148/rg.230133. PMID: 38236751.

>Bohnen NI, Djang DS, Herholz K, Anzai Y, Minoshima S. Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature. J Nucl Med. 2012 Jan;53(1):59-71. doi: 10.2967/jnumed.111.096578. Epub 2011 Dec 15. PMID: 22173840.

>Mokri B. Radioisotope cisternography in spontaneous CSF leaks: interpretations and misinterpretations. Headache. 2014 Sep;54(8):1358-68. doi: 10.1111/head.12421. Epub 2014 Jul 4. PMID: 25041119.

Boero G, Lauriero F, Fusillo D, Calvello R, Cianciulli A, Panaro MA, Moda P. 18F-FDG PET/CT in early phase of sporadic Creutzfeldt-Jacob disease: A case report. Clin Case Rep. 2024 Jun 28;12(7):e8974. doi: 10.1002/ccr3.8974. PMID: 38947537; PMCID: PMC11213690.

Matalon SA, Mamon HJ, Fuchs CS, Doyle LA, Tirumani SH, Ramaiya NH, Rosenthal MH. Anorectal Cancer: Critical Anatomic and Staging Distinctions That Affect Use of Radiation Therapy. Radiographics. 2015 Nov-Dec;35(7):2090-107. doi: 10.1148/rg.2015150037. PMID: 26562239; PMCID: PMC4664281.

Langsteger W, Rezaee A, Pirich C, Beheshti M. 18F-NaF-PET/CT and 99mTc-MDP Bone Scintigraphy in the Detection of Bone Metastases in Prostate Cancer. Semin Nucl Med. 2016 Nov;46(6):491-501. doi: 10.1053/j.semnuclmed.2016.07.003. Epub 2016 Sep 13. PMID: 27825429.

Venema CM, de Vries EFJ, van der Veen SJ, Dorrius MD, van Kruchten M, Schröder CP, Hospers GAP, Glaudemans AWJM. Enhanced pulmonary uptake on 18F-FES-PET/CT scans after irradiation of the thoracic area: related to fibrosis? EJNMMI Res. 2019 Aug 23;9(1):82. doi: 10.1186/s13550-019-0549-y. PMID: 31444658; PMCID: PMC6708021.

Iyer PC, Cabanillas ME, Waguespack SG, Hu MI, Thosani S, Lavis VR, Busaidy NL, Subudhi SK, Diab A, Dadu R. Immune-Related Thyroiditis with Immune Checkpoint Inhibitors. Thyroid. 2018 Oct;28(10):1243-1251. doi: 10.1089/thy.2018.0116. PMID: 30132401; PMCID: PMC6157359.

Sharp SE, Trout AT, Weiss BD, Gelfand MJ. MIBG in Neuroblastoma Diagnostic Imaging and Therapy. Radiographics. 2016 Jan-Feb;36(1):258-78. doi: 10.1148/rg.2016150099. PMID: 26761540.

Parida GK, Roy SG, Kumar R. FDG-PET/CT in Skeletal Muscle: Pitfalls and Pathologies. Semin Nucl Med. 2017 Jul;47(4):362-372. doi: 10.1053/j.semnuclmed.2017.02.003. Epub 2017 Apr 20. PMID: 28583276.

Gafita A, Wang H, Robertson A, Armstrong WR, Zaum R, Weber M, Yagubbayli F, Kratochwil C, Grogan TR, Nguyen K, Navarro F, Esfandiari R, Rauscher I, Menze B, Elashoff D, Delpassand ES, Herrmann K, Czernin J, Hofman MS, Calais J, Fendler WP, Eiber M. Tumor Sink Effect in 68Ga-PSMA-11 PET: Myth or Reality? J Nucl Med. 2022 Feb;63(2):226-232. doi: 10.2967/jnumed.121.261906. Epub 2021 May 28. PMID: 34049987; PMCID: PMC8805781.

Kurland BF, Peterson LM, Lee JH, Schubert EK, Currin ER, Link JM, Krohn KA, Mankoff DA, Linden HM. Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast Cancer. Clin Cancer Res. 2017 Jan 15;23(2):407-415. doi: 10.1158/1078-0432.CCR-16-0362. Epub 2016 Jun 24. PMID: 27342400; PMCID: PMC5183531.

Kalli S, Semine A, Cohen S, Naber SP, Makim SS, Bahl M. American Joint Committee on Cancer’s Staging System for Breast Cancer, Eighth Edition: What the Radiologist Needs to Know. Radiographics. 2018 Nov-Dec;38(7):1921-1933. doi: 10.1148/rg.2018180056. Epub 2018 Sep 28. PMID: 30265613.

Groheux D, Cochet A, Humbert O, Alberini JL, Hindié E, Mankoff D. ¹8F-FDG PET/CT for Staging and Restaging of Breast Cancer. J Nucl Med. 2016 Feb;57 Suppl 1:17S-26S. doi: 10.2967/jnumed.115.157859. PMID: 26834096.

Akkas, Burcu E.; Vural, Gulin U.. The incidence of secondary central nervous system involvement in patients with non-Hodgkin’s lymphoma as detected by 18F-FDG PET/CT. Nuclear Medicine Communications 34(1):p 50-56, January 2013. | DOI: 10.1097/MNM.0b013e32835aaa48  https://pubmed.ncbi.nlm.nih.gov/23111376/

Cheah CY, George A, Giné E, Chiappella A, Kluin-Nelemans HC, Jurczak W, Krawczyk K, Mocikova H, Klener P, Salek D, Walewski J, Szymczyk M, Smolej L, Auer RL, Ritchie DS, Arcaini L, Williams ME, Dreyling M, Seymour JF; European Mantle Cell Lymphoma Network. Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network. Ann Oncol. 2013 Aug;24(8):2119-23. doi: 10.1093/annonc/mdt139. Epub 2013 Apr 24. PMID: 23616279.  https://pubmed.ncbi.nlm.nih.gov/23616279/

Lim CH, Hyun SH, Moon SH, Cho YS, Choe YS, Lee KH, Kim BT, Choi JY. Clinical Significance of Incidental Focal 18F-FDG Uptake in the Spinal Cord of Patients with Cancer. Nucl Med Mol Imaging. 2017 Sep;51(3):247-251. doi: 10.1007/s13139-016-0468-z. Epub 2017 Jan 31. PMID: 28878851; PMCID: PMC5567623.

Bombardieri E, Giammarile F, Aktolun C, Baum RP, Bischof Delaloye A, Maffioli L, Moncayo R, Mortelmans L, Pepe G, Reske SN, Castellani MR, Chiti A; European Association for Nuclear Medicine. 131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2436-46. doi: 10.1007/s00259-010-1545-7. PMID: 20644928.

Weber WA, Ziegler SI, Thödtmann R, Hanauske AR, Schwaiger M. Reproducibility of metabolic measurements in malignant tumors using FDG PET. J Nucl Med. 1999 Nov;40(11):1771-7. PMID: 10565769.

Lodge MA. Repeatability of SUV in Oncologic 18F-FDG PET. J Nucl Med. 2017 Apr;58(4):523-532. doi: 10.2967/jnumed.116.186353. Epub 2017 Feb 23. PMID: 28232605; PMCID: PMC5373499.

Adreview (Iobenguane I 123 Injection) full prescribing information.

Li D, Meng Z, Zhang G, Yu T, Tan J, Dong F. Visualization of thyroglossal duct cyst in differentiated thyroid cancer patient. Clin Nucl Med. 2010 Jul;35(7):499-504. doi: 10.1097/RLU.0b013e3181e05fe3. PMID: 20548141.

Gontier E, Fourme E, Wartski M, Blondet C, Bonardel G, Le Stanc E, Mantzarides M, Foehrenbach H, Pecking AP, Alberini JL. High and typical 18F-FDG bowel uptake in patients treated with metformin. Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):95-9. doi: 10.1007/s00259-007-0563-6. Epub 2007 Sep 5. PMID: 17786437.

Ozülker T, Ozülker F, Mert M, Ozpaçaci T. Clearance of the high intestinal (18)F-FDG uptake associated with metformin after stopping the drug. Eur J Nucl Med Mol Imaging. 2010 May;37(5):1011-7. doi: 10.1007/s00259-009-1330-7. Epub 2010 Jan 27. PMID: 20107796.

Shen C. Peritoneal Metastasis of Osteosarcoma in 99m Tc-MDP SPECT/CT Imaging. Clin Nucl Med. 2024 Nov 1;49(11):e587-e588. doi: 10.1097/RLU.0000000000005436. Epub 2024 Sep 2. PMID: 39235166.

Daldrup-Link HE, Franzius C, Link TM, Laukamp D, Sciuk J, Jürgens H, Schober O, Rummeny EJ. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol. 2001 Jul;177(1):229-36. doi: 10.2214/ajr.177.1.1770229. PMID: 11418435.

Nadel HR. “Nuclear Oncology in Children”. Nuclear Medicine Annual 1996;143-193.

Deandreis D, Leboulleux S, Caramella C, Schlumberger M, Baudin E. FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma. Horm Cancer. 2011 Dec;2(6):354-62. doi: 10.1007/s12672-011-0091-5. PMID: 22076881; PMCID: PMC10358045.

Lebtahi N, Gudinchet F, Nenadov-Beck M, Beck D, Bischof Delaloye A. Evaluating bone marrow metastasis of neuroblastoma with iodine-123-MIBG scintigraphy and MRI. J Nucl Med. 1997 Sep;38(9):1389-92. PMID: 9293795.

Kim J, Yoo SW, Kang SR, Bom HS, Song HC, Min JJ. Clinical implication of F-18 FDG PET/CT in patients with secondary hemophagocytic lymphohistiocytosis. Ann Hematol. 2014 Apr;93(4):661-7. doi: 10.1007/s00277-013-1906-y. Epub 2013 Sep 24. PubMed PMID: 24061788.

Kwak JJ, Tirumani SH, Van den Abbeele AD, Koo PJ, Jacene HA. Cancer immunotherapy: imaging assessment of novel treatment response patterns and immune-related adverse events. Radiographics. 2015 Mar-Apr;35(2):424-37. doi: 10.1148/rg.352140121. PMID: 25763727.

Tirumani SH, Ramaiya NH, Keraliya A, Bailey ND, Ott PA, Hodi FS, Nishino M. Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab. Cancer Immunol Res. 2015 Oct;3(10):1185-92. doi: 10.1158/2326-6066.CIR-15-0102. Epub 2015 Jun 22. PMID: 26100356; PMCID: PMC4596761.

Iyer RB, Balachandran A, Bruzzi JF, Johnson V, Macapinlac HA, Munden RF. PET/CT and hepatic radiation injury in esophageal cancer patients. Cancer Imaging. 2007 Nov 26;7(1):189-94. doi: 10.1102/1470-7330.2007.0027. PMID: 18055293; PMCID: PMC2151325.

McDougall IR. Metastatic struma ovarii: the burden of truth. Clin Nucl Med. 2006 Jun;31(6):321-4. doi: 10.1097/01.rlu.0000218539.51019.cb. PMID: 16714888.

Sacks A, Peller PJ, Surasi DS, Chatburn L, Mercier G, Subramaniam RM. Value of PET/CT in the management of primary hepatobiliary tumors, part 2. AJR Am J Roentgenol. 2011 Aug;197(2):W260-5. doi: 10.2214/AJR.11.6995. PMID: 21785051.

Toriihara A, Yamaga E, Nakadate M, Oyama J, Tateishi U. Detection of unexpected emergency diseases using FDG-PET/CT in oncology patients. Jpn J Radiol. 2017 Sep;35(9):539-545. doi: 10.1007/s11604-017-0664-5. Epub 2017 Jul 3. PMID: 28674772.

Kaltsas G, Caplin M, Davies P, Ferone D, Garcia-Carbonero R, Grozinsky-Glasberg S, Hörsch D, Tiensuu Janson E, Kianmanesh R, Kos-Kudla B, Pavel M, Rinke A, Falconi M, de Herder WW; Antibes Consensus Conference participants. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors. Neuroendocrinology. 2017;105(3):245-254. doi: 10.1159/000461583. Epub 2017 Mar 2. PMID: 28253514; PMCID: PMC5637287.

Hope TA, Bergsland EK, Bozkurt MF, Graham M, Heaney AP, Herrmann K, Howe JR, Kulke MH, Kunz PL, Mailman J, May L, Metz DC, Millo C, O’Dorisio S, Reidy-Lagunes DL, Soulen MC, Strosberg JR. Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors. J Nucl Med. 2018 Jan;59(1):66-74. doi: 10.2967/jnumed.117.202275. Epub 2017 Oct 12. PMID: 29025982; PMCID: PMC6910630.

Hope TA, Abbott A, Colucci K, Bushnell DL, Gardner L, Graham WS, Lindsay S, Metz DC, Pryma DA, Stabin MG, Strosberg JR. NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE. J Nucl Med. 2019 Jul;60(7):937-943. doi: 10.2967/jnumed.118.230607. PMID: 31263080.

Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, Verzijlbergen FJ, Barrington SF, Pike LC, Weber WA, Stroobants S, Delbeke D, Donohoe KJ, Holbrook S, Graham MM, Testanera G, Hoekstra OS, Zijlstra J, Visser E, Hoekstra CJ, Pruim J, Willemsen A, Arends B, Kotzerke J, Bockisch A, Beyer T, Chiti A, Krause BJ; European Association of Nuclear Medicine (EANM). FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54. doi: 10.1007/s00259-014-2961-x. Epub 2014 Dec 2. PMID: 25452219; PMCID: PMC4315529.

Roy FN, Beaulieu S, Boucher L, Bourdeau I, Cohade C. Impact of intravenous insulin on 18F-FDG PET in diabetic cancer patients. J Nucl Med. 2009 Feb;50(2):178-83. doi: 10.2967/jnumed.108.056283. Epub 2009 Jan 21. PMID: 19164226.

Hall MN, Jagannathan JP, Ramaiya NH, Shinagare AB, Van den Abbeele AD. Imaging of extraosseous myeloma: CT, PET/CT, and MRI features. AJR Am J Roentgenol. 2010 Nov;195(5):1057-65. doi: 10.2214/AJR.10.4384. PMID: 20966307.

Bartel TB, Kuruva M, Gnanasegaran G, Beheshti M, Cohen EJ, Weissman AF, Yarbrough TL. SNMMI Procedure Standard for Bone Scintigraphy 4.0. J Nucl Med Technol. 2018 Dec;46(4):398-404. PMID: 30518604.

Gnanasegaran G, Cook G, Adamson K, Fogelman I. Patterns, variants, artifacts, and pitfalls in conventional radionuclide bone imaging and SPECT/CT. Semin Nucl Med. 2009 Nov;39(6):380-95. doi: 10.1053/j.semnuclmed.2009.07.003. PMID: 19801218.

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020. PMID: 26462967; PMCID: PMC4739132.

Hamada N, Fujimichi Y. Classification of radiation effects for dose limitation purposes: history, current situation and future prospects. J Radiat Res. 2014 Jul;55(4):629-40. doi: 10.1093/jrr/rru019. Epub 2014 May 3. PMID: 24794798; PMCID: PMC4100010.

Regulations NRC, 10 CFR, https://www.nrc.gov/reading-rm/doc-collections/cfr/part020/part020-1906.html

Mettler, F. A., Guiberteau, M. J. (2019). Essentials of Nuclear Medicine and Molecular Imaging. Elsevier.

Bartel TB, Kuruva M, Gnanasegaran G, Beheshti M, Cohen EJ, Weissman AF, Yarbrough TL. SNMMI Procedure Standard for Bone Scintigraphy 4.0. J Nucl Med Technol. 2018 Dec;46(4):398-404. PMID: 30518604.

Physical Aspects of Pediatric Nuclear Medicine Imaging in: Treves ST, ed. Pediatric Nuclear Medicine and Molecular Imaging. Springer, 2014.

U.S. NUCLEAR REGULATORY COMMISSION, REGULATORY GUIDE 8.39 REVISION 1, RELEASE OF PATIENTS ADMINISTERED RADIOACTIVE MATERIAL, https://www.nrc.gov/docs/ML1923/ML19232A081.pdf

Emond EC, Groves AM, Hutton BF, Thielemans K. Effect of positron range on PET quantification in diseased and normal lungs. Phys Med Biol. 2019 Oct 16;64(20):205010. doi: 10.1088/1361-6560/ab469d. PMID: 31539891.

Vyas M, Tafti D. Nuclear Medicine Quality Assurance. [Updated 2022 Sep 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK576382/

Gonzalez-Montoro A, Ullah MN, Levin CS. Advances in Detector Instrumentation for PET. J Nucl Med. 2022 Aug;63(8):1138-1144. doi: 10.2967/jnumed.121.262509. PMID: 35914819; PMCID: PMC9364348.

Sgouros G, Roeske JC, McDevitt MR, Palm S, Allen BJ, Fisher DR, Brill AB, Song H, Howell RW, Akabani G; SNM MIRD Committee; Bolch WE, Brill AB, Fisher DR, Howell RW, Meredith RF, Sgouros G, Wessels BW, Zanzonico PB. MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy. J Nucl Med. 2010 Feb;51(2):311-28. doi: 10.2967/jnumed.108.058651. Epub 2010 Jan 15. PMID: 20080889; PMCID: PMC5680544.

Kodzwa R. ACR Manual on Contrast Media: 2018 Updates. Radiol Technol. 2019 Sep;91(1):97-100. PMID: 31471485.

Wright CL, Zhang J, Tweedle MF, Knopp MV, Hall NC. Theranostic Imaging of Yttrium-90. Biomed Res Int. 2015;2015:481279. doi: 10.1155/2015/481279. Epub 2015 May 28. PMID: 26106608; PMCID: PMC4464848.

Essentials of Nuclear Medicine Physics, Instrumentation, and Radiation Biology, 4th Edition, Powsner et al.

Zanzonico P. Principles of nuclear medicine imaging: planar, SPECT, PET, multi-modality, and autoradiography systems. Radiat Res. 2012 Apr;177(4):349-64. doi: 10.1667/rr2577.1. Epub 2012 Feb 27. PMID: 22364319.

Jha A, Patel M, Carrasquillo JA, Chen CC, Millo C, Maass-Moreno R, Ling A, Lin FI, Lechan RM, Hope TA, Taïeb D, Civelek AC, Pacak K. Choice Is Good at Times: The Emergence of [64Cu]Cu-DOTATATE-Based Somatostatin Receptor Imaging in the Era of [68Ga]Ga-DOTATATE. J Nucl Med. 2022 Sep;63(9):1300-1301. doi: 10.2967/jnumed.122.264183. Epub 2022 May 26. Erratum in: J Nucl Med. 2022 Oct;63(10):1597. PMID: 35618479; PMCID: PMC9454463.

Gopal B. Saha. Physics and Radiobiology of Nuclear Medicine. 4th ed. 2013. Springer-Verlag New York.

INTERNATIONAL ATOMIC ENERGY AGENCY, Nuclear Medicine Physics, , IAEA, Vienna (2015).

Jødal L. Beta emitters and radiation protection. Acta Oncol. 2009;48(2):308-13. doi: 10.1080/02841860802245163. PMID: 18766999.

Thyrogen package insert; https://products.sanofi.us/Thyrogen/Thyrogen.pdf

Sartor O, Coleman RE, Nilsson S, Heinrich D, Helle SI, O’Sullivan JM, Vogelzang NJ, Bruland Ø, Kobina S, Wilhelm S, Xu L, Shan M, Kattan MW, Parker C. An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223. Ann Oncol. 2017 May 1;28(5):1090-1097. doi: 10.1093/annonc/mdx044. PMID: 28453701; PMCID: PMC5406754.

Sartor O, Coleman R, Nilsson S, Heinrich D, Helle SI, O’Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Widmark A, Johannessen DC, Hoskin P, James ND, Solberg A, Syndikus I, Vogelzang NJ, O’Bryan-Tear CG, Shan M, Bruland ØS, Parker C. Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial. Lancet Oncol. 2014 Jun;15(7):738-46. doi: 10.1016/S1470-2045(14)70183-4. Epub 2014 May 13. PMID: 24836273.

Xofigo® Prescribing Information, Revised: 12/2019, https://labeling.bayerhealthcare.com/html/products/pi/Xofigo_PI.pdf

Kratochwil C, Fendler WP, Eiber M, Baum R, Bozkurt MF, Czernin J, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen W, Rahbar K, Schöder H, Virgolini I, Wester HJ, Bodei L, Fanti S, Haberkorn U, Herrmann K. EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2536-2544. doi: 10.1007/s00259-019-04485-3. Epub 2019 Aug 22. PMID: 31440799.

Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S; American Thyroid Association Guidelines Task Force. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015 Jul;25(7):716-59. doi: 10.1089/thy.2014.0460. PMID: 25900731; PMCID: PMC4854274.

Hope TA, Pavel M, Bergsland EK. Neuroendocrine Tumors and Peptide Receptor Radionuclide Therapy: When Is the Right Time? J Clin Oncol. 2022 Aug 20;40(24):2818-2829. doi: 10.1200/JCO.22.00176. Epub 2022 Jun 1. PMID: 35649195; PMCID: PMC9390818.

Strosberg JR, Al-Toubah T, Pellè E, Smith J, Haider M, Hutchinson T, Fleming JB, El-Haddad G. Risk of Bowel Obstruction in Patients with Mesenteric or Peritoneal Disease Receiving Peptide Receptor Radionuclide Therapy. J Nucl Med. 2021 Jan;62(1):69-72. doi: 10.2967/jnumed.120.242875. Epub 2020 May 22. PMID: 32444368.

Silberstein EB, Alavi A, Balon HR, Clarke SE, Divgi C, Gelfand MJ, Goldsmith SJ, Jadvar H, Marcus CS, Martin WH, Parker JA, Royal HD, Sarkar SD, Stabin M, Waxman AD. The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0. J Nucl Med. 2012 Oct;53(10):1633-51. doi: 10.2967/jnumed.112.105148. Epub 2012 Jul 11. PMID: 22787108.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208700s000lbl.pdf

Larson SM,  SM and Krenning EP: Clinical Practice of Molecular Radiotherapy” Supplement J. Nucl. Med. January, 2005. 204 pp.

Acharya SH, Avenell A, Philip S, Burr J, Bevan JS, Abraham P. Radioiodine therapy (RAI) for Graves’ disease (GD) and the effect on ophthalmopathy: a systematic review. Clin Endocrinol (Oxf). 2008 Dec;69(6):943-50. doi: 10.1111/j.1365-2265.2008.03279.x. Epub 2008 Apr 21. PMID: 18429949.

NRC 10 CFR 35.75 Patient Release criteria

American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009 Nov;19(11):1167-214. doi: 10.1089/thy.2009.0110. Erratum in: Thyroid. 2010 Aug;20(8):942. Hauger, Bryan R [corrected to Haugen, Bryan R]. Erratum in: Thyroid. 2010 Jun;20(6):674-5. PMID: 19860577.

Xofigo package insert

Lutathera package insert

U.S. NUCLEAR REGULATORY COMMISSION, REGULATORY GUIDE 8.39 REVISION 1, RELEASE OF PATIENTS

ADMINISTERED RADIOACTIVE MATERIAL, https://www.nrc.gov/docs/ML1923/ML19232A081.pdf

NRC guidance-https://www.nrc.gov/docs/ML1726/ML17262A909.pdf

Coover LR, Silberstein EB, Kuhn PJ, Graves MW. Therapeutic 131I in outpatients: a simplified method conforming to the Code of Federal Regulations, title 10, part 35.75. J Nucl Med. 2000 Nov;41(11):1868-75. PMID: 11079497.

Derenoncourt PR, Felder GJ, Royal HD, Bhalla S, Lang JA, Matesan MC, Itani M. Ventilation-Perfusion Scan: A Primer for Practicing Radiologists. Radiographics. 2021 Nov-Dec;41(7):2047-2070. doi: 10.1148/rg.2021210060. Epub 2021 Oct 22. PMID: 34678101.

Remy-Jardin M, Ryerson CJ, Schiebler ML, Leung ANC, Wild JM, Hoeper MM, Alderson PO, Goodman LR, Mayo J, Haramati LB, Ohno Y, Thistlethwaite P, van Beek EJR, Knight SL, Lynch DA, Rubin GD, Humbert M. Imaging of pulmonary hypertension in adults: a position paper from the Fleischner Society. Eur Respir J. 2021 Jan 5;57(1):2004455. doi: 10.1183/13993003.04455-2020. PMID: 33402372.

Pulmonary Hypertension: Pearls and Pitfalls of Diagnosis. Methodist Debakey Cardiovasc J. 2016 Oct-Dec;12(4):199-204. doi: 10.14797/mdcj-12-4-199. PMID: 28289494; PMCID: PMC5344469.

Bowman AW, Albers BK, Jain MK. Acquired Whole-lung Mismatched Perfusion Defects on Pulmonary Ventilation/Perfusion Scintigraphy. Indian J Nucl Med. 2018 Oct-Dec;33(4):312-316. doi: 10.4103/ijnm.IJNM_60_18. PMID: 30386053; PMCID: PMC6194779.

Milanesi O, Stellin G, Zucchetta P. Nuclear Medicine in Pediatric Cardiology. Semin Nucl Med. 2017 Mar;47(2):158-169. doi: 10.1053/j.semnuclmed.2016.10.008. Epub 2017 Jan 10. PMID: 28237004.

Levin DP, Pison CF, Brandt M, Weber A, Paradis K, Laberge JM, Blanchard H. Reversal of intrapulmonary shunting in cirrhosis after liver transplantation demonstrated by perfusion lung scan. J Nucl Med. 1991 May;32(5):862-4. PMID: 2022996.

Ventilation/Perfusion Scintigraphy , William G. Spies in Nuclear Medicine , Vol 2, Chapter 90, text book by Robert Henkin

Cowper SE, Boyer PJ. Nephrogenic systemic fibrosis: an update. Curr Rheumatol Rep. 2006 Apr;8(2):151-7. doi: 10.1007/s11926-006-0056-9. PMID: 16569375.

Mostafa M, Vali R, Chan J, Omarkhail Y, Shammas A. Variants and pitfalls on radioiodine scans in pediatric patients with differentiated thyroid carcinoma. Pediatr Radiol. 2016 Oct;46(11):1579-89. doi: 10.1007/s00247-016-3655-2. Epub 2016 Aug 3. PMID: 27488505.

Yap FY, Skalski MR, Patel DB, Schein AJ, White EA, Tomasian A, Masih S, Matcuk GR Jr. Hypertrophic Osteoarthropathy: Clinical and Imaging Features. Radiographics. 2017 Jan-Feb;37(1):157-195. doi: 10.1148/rg.2017160052. Epub 2016 Dec 9. PMID: 27935768.

Smith SE, Murphey MD, Motamedi K, Mulligan ME, Resnik CS, Gannon FH. From the archives of the AFIP. Radiologic spectrum of Paget disease of bone and its complications with pathologic correlation. Radiographics. 2002 Sep-Oct;22(5):1191-216. doi: 10.1148/radiographics.22.5.g02se281191. PMID: 12235348.

Palestro CJ. Radionuclide Imaging of Musculoskeletal Infection: A Review. J Nucl Med. 2016 Sep;57(9):1406-12. doi: 10.2967/jnumed.115.157297. Epub 2016 Jul 7. PMID: 27390160.

Goodin GS, Shulkin BL, Kaufman RA, McCarville MB. PET/CT characterization of fibroosseous defects in children: 18F-FDG uptake can mimic metastatic disease. AJR Am J Roentgenol. 2006 Oct;187(4):1124-8. doi: 10.2214/AJR.06.0171. Erratum in: AJR Am J Roentgenol. 2006 Nov;187(5):1146. PMID: 16985165.

Palestro CJ. Radionuclide imaging of osteomyelitis. Semin Nucl Med. 2015 Jan;45(1):32-46. doi: 10.1053/j.semnuclmed.2014.07.005. PMID: 25475377.